Inventors:
- Ingelheim am Rhein, DE
Mary Ruth Flack - Ridgefield CT, US
Annette Bettina Galler - Armsheim, DE
Bojan Lalovic - Cedar Knolls NJ, US
Kaori Maino - Tokyo, JP
Steven John Padula - Southbury CT, US
Paul Scholl - Redding CT, US
Koji Sha - Tokyo, JP
Sudha Visvanathan - Hartsdale NY, US
Assignee:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH - Ingelheim am Rhein
International Classification:
C07K 16/24
A61K 39/395
A61P 17/06
C12Q 1/6883
Abstract:
This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as psoriasis or psoriatic arthritis, utilizing anti-IL-23A antibodies.